In late December, FDA alerted drug compounders and manufacturers that drug shipments from Tianjin, China may be at risk of chemical contamination from two massive explosions at the Tianjin Dongjiang Port Ruihai International Logistics Company chemical warehouse in August 2015. FDA has found hydrogen cyanide contamination in two shipments of drugs from Tianjin Tianyao Pharmaceuticals Company located in Tianjian, approximately 30 kilometers (18 miles) from the explosion site. Two other shipments from the company were found not to contain hydrogen cyanide. FDA notes that the shipments appear to have been intended for use in pharmacy compounding. The announcement reminds drug manufacturers and compounders that source finished drug products, active pharmaceutical ingredients (APIs) and excipients from the Tianjin City region to that it is their responsibility to ensure that all shipments they receive “are free from contamination associated with the explosion and not contaminated in any way.”
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
